ArticlePediatric obesity2026
Specific Fat Depots and Cardiometabolic Risk and Insulin Resistance in Children With Obesity.
Article in Pediatric obesity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Differences in Fat Depots, Cardiometabolic Risk Factors, and Insulin Resistance Between Active and Passive School Commuters.Pediatric obesity · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundIn children, the impact of specific fat depots, particularly ectopic depots, on cardiometabolic health has been scarcely investigated. Therefore, we aimed to investigate the associations of various specific fat depots with cardiometabolic risk and insulin resistance in children with overweight/obesity.
methodsOne hundred fourteen children with overweight/obesity (54.4% girls, 10.6 ± 1.1 years) were included. Fat depots including abdominal visceral (VAT), subcutaneous (ASAT), and intermuscular (IMAAT) adipose tissue, lumbar spine bone marrow, hepatic and pancreatic fat were measured using magnetic resonance imaging. Cardiometabolic risk factors (blood pressure, triglycerides, high-density lipoprotein cholesterol, glucose and insulin) were assessed, and age- and sex-reference based cardiometabolic risk score and insulin resistance were calculated.
resultsIn univariate analysis, VAT, ASAT, IMAAT and hepatic fat were significantly associated with cardiometabolic risk score (β = 0.308-0.526, p ≤ 0.001) and insulin resistance (β = 0.227-0.412, p < 0.05). However, after adjusting for other fat variables, VAT was the only fat depot independently associated with cardiometabolic risk score (β = 0.450, p < 0.001), while ASAT was the only fat depot independently associated with insulin resistance (β = 0.393, p < 0.001). Hepatic fat did not show an independent association with either cardiometabolic risk score or insulin resistance (p ≥ 0.256).
conclusionIn this population, VAT and ASAT appear to be independent predictors of cardiometabolic risk and insulin resistance, respectively.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.